Representatives from the Princess Máxima Center, the Hopp Children's Cancer Center Heidelberg (KiTZ), and the Institut Curie in Paris signed a memorandum of understanding on strategic collaboration in European pediatric oncology. The signing ceremony took place at the Mauritshuis in The Hague, in the presence of Queen Máxima, the namesake of the Princess Máxima Center.
The 'EU CAN KIDS' (European Alliance for a Childhood Without Cancer) initiative, originally established between KiTZ and the Princess Máxima Center in 2021, is now being expanded to include another European partner. The alliance's research fund aims to significantly advance European childhood cancer research, focusing on developing therapies with fewer side effects specifically tailored to children.
The alliance aims to advance new treatment approaches in immunotherapy and targeted therapy for children, as well as to establish patient-specific lab models. These models enable the replication of individual patients’ tumors in the lab, allowing their responses to specific drugs to be tested in advance. Expanding infrastructure and fostering leading talent in pediatric cancer research are also key priorities.
Post a Comment
(We will not publish anonymous comments that were posted without stating a name or nickname)